Product NDC: | 59011-442 |
Proprietary Name: | Dilaudid |
Non Proprietary Name: | hydromorphone hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; hydromorphone hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59011-442 |
Labeler Name: | Purdue Pharma LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019034 |
Marketing Category: | NDA |
Start Marketing Date: | 19260101 |
Package NDC: | 59011-442-25 |
Package Description: | 25 AMPULE in 1 CARTON (59011-442-25) > 2 mL in 1 AMPULE |
NDC Code | 59011-442-25 |
Proprietary Name | Dilaudid |
Package Description | 25 AMPULE in 1 CARTON (59011-442-25) > 2 mL in 1 AMPULE |
Product NDC | 59011-442 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hydromorphone hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19260101 |
Marketing Category Name | NDA |
Labeler Name | Purdue Pharma LP |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |